Ultra-Precise Cancer Monitoring in 24 Hours

ExoDiscovery Monitor analyzes RNA biomarkers within exosomes, achieving 10,000x greater sensitivity than conventional methods. This revolutionary approach enables detection of emerging resistance mutations and treatment response assessment with unprecedented precision, allowing for timely therapy adjustments.

While conventional monitoring tests require 7-14 days for results, ExoDiscovery Monitor delivers complete mutation analysis in just 24 hours. This dramatic reduction in waiting time enables faster clinical decision-making, reduces patient anxiety, and allows for more timely therapy adjustments when needed most.

ExoDiscovery Monitor provides precise quantification of variant allele frequencies over time, enabling oncologists to track treatment response, detect early signs of resistance, and make data-driven decisions about therapy continuation or modification. The test complements imaging studies to provide a complete picture of disease status.